Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM
- DOI
- 10.1182/bloodadvances.2025019303
- Published
- 2026-04-29
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025019303,
title = {Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM},
author = {Manali Kamdar and Scott R. Solomon and Jon Arnason and Patrick B. Johnston and Bertram Glass and Veronika Bachanova and Sami Ibrahimi and Stephan Mielke and Pim Mutsaers and Francisco Hernandez-Ilizaliturri and Koji Izutsu and Franck Morschhauser and Matthew Lunning and Vincent Ribrag and Yi Lin and Rashmi Bhatnagar and Robert Braun and Sandrine Montheard and Jeremy S. Abramson},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2025019303},
url = {https://doi.org/10.1182/bloodadvances.2025019303}
}RIS
TY - JOUR TI - Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM AU - Manali Kamdar AU - Scott R. Solomon AU - Jon Arnason AU - Patrick B. Johnston AU - Bertram Glass AU - Veronika Bachanova AU - Sami Ibrahimi AU - Stephan Mielke AU - Pim Mutsaers AU - Francisco Hernandez-Ilizaliturri AU - Koji Izutsu AU - Franck Morschhauser AU - Matthew Lunning AU - Vincent Ribrag AU - Yi Lin AU - Rashmi Bhatnagar AU - Robert Braun AU - Sandrine Montheard AU - Jeremy S. Abramson PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2025019303 UR - https://doi.org/10.1182/bloodadvances.2025019303 ER -
APA
Kamdar, M., Solomon, S. R., Arnason, J., Johnston, P. B., Glass, B., Bachanova, V., Ibrahimi, S., Mielke, S., Mutsaers, P., Hernandez-Ilizaliturri, F., Izutsu, K., Morschhauser, F., Lunning, M., Ribrag, V., Lin, Y., Bhatnagar, R., Braun, R., Montheard, S., & Abramson, J. S. (2026). Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM. Blood Advances. https://doi.org/10.1182/bloodadvances.2025019303
Source records
- crossref · retrieved 2026-09-26T22:13:30.907Z